Summary
Biogen Idec Inc. filed an 8-K on April 16, 2009, primarily to furnish a press release announcing its first-quarter 2009 results. While the 8-K itself does not contain the detailed financial figures, it directs investors to the accompanying press release (Exhibit 99.1) for comprehensive information regarding the company's operational performance and financial condition for the three months ended March 31, 2009. This filing is a standard procedure for disclosing earnings and key financial updates to the market. Investors seeking detailed insights into Biogen Idec's financial health and operational achievements for Q1 2009 should refer to the furnished press release. This includes information on revenue, profitability, and any significant developments or outlook shared by the company during that period. The 8-K serves as a formal notification and makes the press release publicly available through SEC filings.
Key Highlights
- 1Biogen Idec Inc. filed an 8-K on April 16, 2009.
- 2The filing's primary purpose is to announce results of operations and financial condition for the quarter ended March 31, 2009.
- 3The detailed financial information is provided in a press release furnished as Exhibit 99.1.
- 4This filing does not contain the financial results directly but references the external press release.
- 5The press release is incorporated by reference but is not deemed 'filed' for Section 18 of the Exchange Act.
- 6The filing includes standard signatures and exhibit index.